Abundance Wealth Counselors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Abundance Wealth Counselors's VRTX Position: Q2 2026 in Review
Abundance Wealth Counselors increased its Vertex Pharmaceuticals (VRTX) stake by 99% in Q2 2026, buying an estimated $400K and bringing the position to 1,815 shares worth $902K. The position accounts for 0.06% of the portfolio, ranked #141.
Abundance Wealth Counselors first reported a position in VRTX in Q2 2024 and has held it in 7 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Abundance Wealth Counselors held 1,815 shares of Vertex Pharmaceuticals worth $902K as of Q2 2026.
- Abundance Wealth Counselors bought 902 Vertex Pharmaceuticals shares in Q2 2026, an estimated $400K.
- Vertex Pharmaceuticals made up 0.06% of Abundance Wealth Counselors's portfolio in Q2 2026, its #141 holding.
- Abundance Wealth Counselors first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.